Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Phase II study of combination therapy with paclitaxel and carboplatin against postoperative small residual disease in patients with stage I c-IV ovarian cancer--KCOG 989 trial].
Nakata Y, Yamada T, Itoh R, Koishi K, Hiraoka K, Yamagami K, Itani Y, Toyoda S, Itoh K, Kimura T, Hosokawa K, Honjo H, Fujita H, Koshiba H, Hara Y, Tsuchiya H, Adachi S. Nakata Y, et al. Among authors: kimura t. Gan To Kagaku Ryoho. 2002 May;29(5):717-22. Gan To Kagaku Ryoho. 2002. PMID: 12040675 Clinical Trial. Japanese.
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T; ONCO PE Trial Investigators. Yamashita Y, et al. Among authors: kimura t. Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072758. Online ahead of print. Circulation. 2024. PMID: 39556015
Comparison of Magnetic Resonance Imaging Features Between Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitor-Induced Hypopituitarism and Idiopathic Hypopituitarism in Japanese Subjects.
Iwamoto Y, Kimura T, Dan K, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: kimura t. Cureus. 2024 Oct 17;16(10):e71699. doi: 10.7759/cureus.71699. eCollection 2024 Oct. Cureus. 2024. PMID: 39553056 Free PMC article.
Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.
Mori K, Numakura K, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Yamana K, Kandori S, Kimura T, Nishiyama N, Bando Y, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Kitamura H, Miyake H, Habuchi T. Mori K, et al. Among authors: kimura t. Cancer Sci. 2024 Nov 17. doi: 10.1111/cas.16326. Online ahead of print. Cancer Sci. 2024. PMID: 39550694 Free article.
Body mass index and breast cancer risk in premenopausal and postmenopausal East Asian women: a pooled analysis of 13 cohort studies.
Wada K, Kuboyama K, Abe SK, Rahman MS, Islam MR, Saito E, Nagata C, Sawada N, Tamakoshi A, Shu XO, Sakata R, Hozawa A, Kanemura S, Ito H, Sugawara Y, Park SK, Kweon SS, Ono A, Kimura T, Wen W, Oze I, Shin MH, Shin A, Kim J, Lee JE, Matsuo K, Rothman N, Qiao YL, Zheng W, Boffetta P, Inoue M. Wada K, et al. Among authors: kimura t. Breast Cancer Res. 2024 Nov 14;26(1):158. doi: 10.1186/s13058-024-01907-5. Breast Cancer Res. 2024. PMID: 39543702 Free PMC article.
10,387 results
You have reached the last available page of results. Please see the User Guide for more information.